Ranjit Shahani

Rediff.com » News » Ranjit Shahani

News for Ranjit Shahani

Business

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Indian pharma has no incentive to innovate

No one expected, when the first major clinical trial started on Glivec in 2000, that the patients would live much beyond a couple of years.Yet, seven years later, 86 per cent of them were still......

Novartis has 219 patents in India

India’s intent to respect intellectual property may have drawn international criticism following the Supreme Court’s decision on Glivec, but facts point at a different story.After Swiss......

Will not invest on R&D in India, says Novartis

Swiss pharma major Novartis said on Monday it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent......

Sandoz to close generic development centre

Sandoz, the generic arm of Swiss drug maker Novartis, has decided to shut its facility for development of generic drugs in India. The facility, known as Sandoz Development Centre located near......

Rediff News

Ranjit Shahani

News for Ranjit Shahani

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Indian pharma has no incentive to innovate

Novartis has 219 patents in India

Will not invest on R&D in India, says Novartis

Sandoz to close generic development centre

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS